Public Meeting Notice

Public Meeting Notice  Board of Registration in Pharmacy (via Webex) — November 6, 2025

Thursday, November 6, 2025, 2025 at 8:00 a.m.
Posted: October 14, 2025 2:30 p.m.

Overview

This meeting will be by Webex Conference Call.

  • Webinar link
  • Meeting number: 2537 024 7621
  • Webinar Password: BOP123

Join by telephone

  • +1-617-315-0704 United States Toll (Boston)
  • +1-650-479-3208 United States Toll
  • Global call-in numbers | Toll-free calling restrictions 

If you need reasonable accommodations in order to participate in the meeting, contact the DPH ADA Coordinator Stacy Hart, Stacy.Hart@mass.gov or 857-274-1120 in advance of the meeting. While the Board will do its best to accommodate you, certain accommodation may require distinctive requests or the hiring of outside contractors and may not be available if requested immediately before the meeting.

Agenda

TimeItem #Item
8:00ICALL TO ORDER
8:05IIAPPROVAL OF AGENDA
8:10III

APPROVAL OF BOARD MINUTES

  • Draft of October 9, 2025, Regular Session Minutes
8:15IV

REPORTS

  • Applications approved pursuant to Licensure Policy 13-01
  • Monthly report from Probation
  • Board Delegated Review pursuant to Licensure Policy 14-02
  • URAMP report
8:30  V

FLEX

  • Nomination of Board Officers
  • NABP District 1&2 meeting summary
  • New pharmacy labeling requirement (Shield Law 2.0)
  • Pharmacy Advisory Committee meeting summary
  • Recommendation for automated non-sterile compounding devices
8:45VI

POLICY

  • Policy 2020-15: Scope of Practice
8:50VII

APPLICATIONS

  • Freedom Fertility Pharmacy, DS89717
    • Petition for Waiver DSPW10064
  • Freedom FP Fertility Pharmacy, DS89716
    • Petition for Waiver DSPW10086
  • MedMinder Pharmacy, DS90408
    • Waiver Performance Data
  • Medwiz of Mass, LLC DS90404
    • Petition for Waiver
9:30VIII

REVIEW OF COMPLIANCE

  • Option Care, DS90107; PHA-2020-0066, PHA-2022-0016, PHA-2022-0045, PHA-2022-0135, PHA-2023-0267, PHA-2024-0079, PHA-2024-0080, PHA-2024-0081 and PHA-2024-0082
9:45IX

FILE REVIEW

1CASE-2025-0983PHA-2025-0100Christopher Ryan, PH22331 SA to PHA
2CASE-2025-1526PHA-2025-0058CVS/specialty OR CarelonRx Specialty Pharmacy, NDS31709
10:00X

EXECUTIVE SESSION

The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, to evaluate the Good Moral Character as required for registration for a pending applicant. 

10:30XIM.G.L. c. 112, § 65C SESSION
12:00XIIADJOURNMENT

Help Us Improve Mass.gov  with your feedback

Please do not include personal or contact information.
Feedback